Diagnosis and Treatment of ADHD in Adults with Substance Use Disorder: Applying Evidence to a Common Clinical Quandary
Diagnosis and treatment of adult ADHD is on the rise. Patients with substance use disorder are thought to be disproportionately affected by ADHD but how safe is, and what impact does the pharmacologic treatment have? This session will bring together psychiatry and addiction medicine physicians to explore this clinical question. We will present clinical advice about diagnosis, review literature about pharmacologic treatment, and bring experience and evidence together to discuss common clinical questions on this topic.
1. Raise awareness of the complexity of ADHD dx
2. Understand evidence for treatment of adult ADHD alone and with SUD
3. Understand the harms of treatment of adult ADHD
1. Identify considerations in enhancing specificity of making an ADHD diagnosis in adults
2. Describe the evidence for benefit of treatment of adult ADHD, and the limitations of that evidence
3. Outline potential harms of stimulant therapy
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
1.5 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals
1.5 Category I contact hours for psychologists are provided. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1.5 contact hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
1.5 contact hours pending for alcohol and drug counselors from the board of alcohol and drug counselors
Andrea Truncali, MD, MPH is a board-certified physician in both Internal and Addiction Medicine, and an Assistant Professor of Medicine at Tufts University. She completed medical school and residency at New York University, followed by further training in preventive medicine and public health. In pursuit of improving the health and well-being of underserved people, Dr Truncali takes care of patients in specialty substance use treatment as well as primary care settings, provides education and guidance to physicians on the topic of substance use disorder, and contributes to activities at the state level regarding substance use prevention and treatment.
Dr. Moran is the director of the Mclean Pharmacoepidemiology Laboratory Advanced Bioinformatics and Computational Discovery Hub Psychiatrist-in-Charge, Schizophrenia and Bipolar Disorders Inpatient Unit Assistant Professor, Harvard Medical School Department of Psychiatry McLean Hospital.
Dr. Chaplin graduated from Harvard Medical School in 1988. She works in New Britain, CT and 4 other locations and specializes in Addiction Medicine and Psychiatry. Dr. Chaplin is affiliated with Bristol Hospital.